You just read:

Biohaven Enrolls First Patient In Phase 3 Spinocerebellar Ataxia Clinical Trial Of Troriluzole

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

Mar 14, 2019, 07:30 ET